FAAH; FAH1; FAXDC1; SCS7; SPG35
The FA2H gene is associated with autosomal recessive hereditary spastic paraplegia 35 (SPG35) (MedGen UID: 777150).
Order this gene as a single gene test.
Invitae tests that include this gene:
FA2H is a rare cause of hereditary spastic paraplegia, and the percentage of HSP attributed to pathogenic variants identified in FA2H is unknown.
The FA2H gene encodes the fatty acid 2-hydroxylase enzyme, a transmembrane protein in the endoplasmic reticulum that plays an essential role in the synthesis of sphingolipids. These molecules a major component of myelin, which facilitates nerve conduction in the nervous system.
Invitae is a College of American Pathologists (CAP)-accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified clinical diagnostic laboratory performing full-gene sequencing and deletion/duplication analysis using next-generation sequencing technology (NGS).
Our sequence analysis covers clinically important regions of each gene, including coding exons, +/- 10 base pairs of adjacent intronic sequence, and select noncoding variants. Our assay provides a Q30 quality-adjusted mean coverage depth of 350x (50x minimum, or supplemented with additional analysis). Variants classified as pathogenic or likely pathogenic are confirmed with orthogonal methods, except individual variants that have high quality scores and previously validated in at least ten unrelated samples.
Our analysis detects most intragenic deletions and duplications at single exon resolution. However, in rare situations, single-exon copy number events may not be analyzed due to inherent sequence properties or isolated reduction in data quality. If you are requesting the detection of a specific single-exon copy number variation, please contact Client Services before placing your order.
|Gene||Transcript reference||Sequencing analysis||Deletion/Duplication analysis|